- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Pharmacological intervention
- Pycnogenol
Population: Adults
Individuals aged 18-64 years
- Adults
- General population
- Elderly
- Primary care
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Neuromodulation
- Adults
- General population
- Elderly
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- Adults
- General population
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Immunoadsorption
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Hospital wide
- Outpatient clinic
- Intensive care unit
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Hospital wide
- Community
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Hospital wide
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Elderly
- Hospital wide
- SARS-CoV-2
- Post-COVID-19
- Adults
- Elderly
- Paediatric
- Community
- SARS-CoV-2
- Post-COVID-19